Novozymes Future Growth
Future criteria checks 3/6
Novozymes is forecast to grow earnings and revenue by 19.5% and 12.3% per annum respectively. EPS is expected to grow by 11.4% per annum. Return on equity is forecast to be 8.1% in 3 years.
Key information
19.5%
Earnings growth rate
11.4%
EPS growth rate
Chemicals earnings growth | 52.3% |
Revenue growth rate | 12.3% |
Future return on equity | 8.1% |
Analyst coverage | Good |
Last updated | 09 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 33,658 | 6,486 | 6,373 | 9,589 | 7 |
12/31/2025 | 31,457 | 5,531 | 5,222 | 8,381 | 7 |
12/31/2024 | 29,428 | 4,245 | 4,061 | 6,573 | 7 |
12/31/2023 | 17,899 | 3,024 | 2,097 | 4,152 | N/A |
9/30/2023 | 17,825 | 3,209 | 1,263 | 3,614 | N/A |
6/30/2023 | 17,736 | 3,425 | 616 | 3,248 | N/A |
3/31/2023 | 17,805 | 3,628 | 618 | 3,545 | N/A |
12/31/2022 | 17,553 | 3,676 | 1,116 | 4,006 | N/A |
9/30/2022 | 16,858 | 3,418 | 1,528 | 4,117 | N/A |
6/30/2022 | 16,252 | 3,108 | 1,946 | 4,007 | N/A |
3/31/2022 | 15,546 | 3,093 | 2,504 | 3,939 | N/A |
12/31/2021 | 14,951 | 3,146 | 2,822 | 4,062 | N/A |
9/30/2021 | 14,563 | 3,175 | 3,428 | 4,413 | N/A |
6/30/2021 | 14,233 | 3,044 | 3,209 | 4,197 | N/A |
3/31/2021 | 14,002 | 2,895 | 3,293 | 4,290 | N/A |
12/31/2020 | 14,012 | 2,825 | 3,415 | 4,355 | N/A |
9/30/2020 | 14,297 | 3,093 | 3,294 | 3,881 | N/A |
6/30/2020 | 14,570 | 3,020 | 3,463 | 3,997 | N/A |
3/31/2020 | 14,679 | 3,273 | 3,035 | 3,596 | N/A |
12/31/2019 | 14,374 | 3,154 | 2,629 | 3,196 | N/A |
9/30/2019 | 14,357 | 3,069 | 2,358 | 3,436 | N/A |
6/30/2019 | 14,311 | 3,238 | 2,616 | 3,768 | N/A |
3/31/2019 | 14,351 | 3,116 | 2,305 | 3,558 | N/A |
12/31/2018 | 14,390 | 3,226 | 2,287 | 3,679 | N/A |
9/30/2018 | 14,349 | 3,183 | 2,258 | 3,839 | N/A |
6/30/2018 | 14,271 | 3,194 | 1,954 | 3,649 | N/A |
3/31/2018 | 14,311 | 3,154 | 2,048 | 3,738 | N/A |
12/31/2017 | 14,531 | 3,119 | 2,371 | 4,063 | N/A |
9/30/2017 | 14,572 | 3,131 | N/A | 3,963 | N/A |
6/30/2017 | 14,382 | 3,063 | N/A | 3,883 | N/A |
3/31/2017 | 14,273 | 3,077 | N/A | 4,073 | N/A |
12/31/2016 | 14,142 | 3,050 | N/A | 3,840 | N/A |
9/30/2016 | 13,880 | 2,936 | N/A | 3,632 | N/A |
6/30/2016 | 14,012 | 2,929 | N/A | 3,248 | N/A |
3/31/2016 | 14,032 | 2,861 | N/A | 3,353 | N/A |
12/31/2015 | 14,002 | 2,823 | N/A | 3,339 | N/A |
9/30/2015 | 13,731 | 2,734 | N/A | 2,945 | N/A |
6/30/2015 | 13,393 | 2,630 | N/A | 3,308 | N/A |
3/31/2015 | 13,005 | 2,539 | N/A | 3,391 | N/A |
12/31/2014 | 12,459 | 2,526 | N/A | 4,525 | N/A |
9/30/2014 | 12,218 | 2,484 | N/A | 5,061 | N/A |
6/30/2014 | 11,970 | 2,413 | N/A | 4,791 | N/A |
3/31/2014 | 11,934 | 2,379 | N/A | 4,235 | N/A |
12/31/2013 | 11,746 | 2,200 | N/A | 2,599 | N/A |
9/30/2013 | 11,617 | 2,132 | N/A | 2,547 | N/A |
6/30/2013 | 11,519 | 2,085 | N/A | 2,531 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NSIS N's forecast earnings growth (19.5% per year) is above the savings rate (7.7%).
Earnings vs Market: NSIS N's earnings (19.5% per year) are forecast to grow faster than the MX market (10.2% per year).
High Growth Earnings: NSIS N's earnings are forecast to grow, but not significantly.
Revenue vs Market: NSIS N's revenue (12.3% per year) is forecast to grow faster than the MX market (6.8% per year).
High Growth Revenue: NSIS N's revenue (12.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NSIS N's Return on Equity is forecast to be low in 3 years time (8.1%).